GetTopicDetailResponse(id=32801239eba, topicName=mXELIRI, introduction=mXELIRI, content=null, image=null, comments=1, allHits=969, url=https://h5.medsci.cn/topic?id=12397, type=1, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=71837, tagList=[TagDto(tagId=71837, tagName=mXELIRI)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1943863, encodeId=197c19438630f, content=<a href='/topic/show?id=32801239eba' target=_blank style='color:#2F92EE;'>#mXELIRI#</a>, objectTitle=Lancet oncol:mXELIRI或許可以替換FOLFIRI作為轉(zhuǎn)移性結(jié)直腸癌的標準二線療法, objectType=article, longId=132833, objectId=67b213283312, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=67b213283312, replyNumber=0, likeNumber=76, createdTime=2019-01-08, rootId=0, userName=dongjia2010, userId=3547346, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=67b213283312, moduleTitle=Lancet oncol:mXELIRI或許可以替換FOLFIRI作為轉(zhuǎn)移性結(jié)直腸癌的標準二線療法, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=67b213283312)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29